These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11845064)

  • 1. [Hemolitic uremic syndrome with hypertransaminasemia following treatment by interferon for chronic myeloid leukemia].
    Denizon N; Beraud JJ; Mourad G; Blanc P; Bureau JP; Navarro M; Lavabre-Bertrand T
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1039-40. PubMed ID: 11845064
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemolytic uremic syndrome-like episode following nonmyeloablative hematopoietic stem cell transplantation in a patient with chronic myeloid leukemia].
    Takahashi N; Miura I; Kume M; Kawabata Y; Hirokawa M; Sawada K
    Rinsho Ketsueki; 2003 Jun; 44(6):391-5. PubMed ID: 12884818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
    Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM
    Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of chronic myelogenous leukemia with hemolytic-uremic-syndrome like kidney during long-term interferon-alpha therapy].
    Kobayashi H; Utsunomiya Y; Miyazaki Y; Tokutome G; Kawamura T; Hashimoto T; Sakai T; Takahashi S; Tojyo A; Asano S
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1259-61. PubMed ID: 9379108
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha.
    Schlaifer D; Dumazer P; Spenatto N; Mignon-Conte M; Brousset P; Lumbroso C; Cooper M; Muller C; Huguet F; Attal M
    Am J Hematol; 1994 Nov; 47(3):254-5. PubMed ID: 7942805
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
    Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
    Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
    [No Abstract]   [Full Text] [Related]  

  • 8. Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
    Ohashi N; Yonemura K; Sugiura T; Isozaki T; Togawa A; Fujigaki Y; Yamamoto T; Hishida A
    Am J Kidney Dis; 2003 Mar; 41(3):E10. PubMed ID: 12613003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interferon-alpha in chronic myeloid leukemia.
    Kumar L; Basade M; Gulati SC
    J Assoc Physicians India; 1995; Suppl 3():26-32. PubMed ID: 8773119
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant interferon alpha and hemolytic uremic syndrome: cause or coincidence?
    Harvey M; Rosenfeld D; Davies D; Hall BM
    Am J Hematol; 1994 Jun; 46(2):152-3. PubMed ID: 8172186
    [No Abstract]   [Full Text] [Related]  

  • 11. CML may not be part of HUS.
    Lipton JH; Minden M
    Am J Hematol; 1995 May; 49(1):100-1. PubMed ID: 7741131
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon-alpha is effective in the treatment of chronic hepatitis C.
    Worman HJ
    Am J Gastroenterol; 1995 Apr; 90(4):679-80. PubMed ID: 7717348
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic myeloid leukemia with alpha interferons].
    Guilhot F
    Nouv Rev Fr Hematol (1978); 1991; 33(2):200-1. PubMed ID: 1766853
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapidly progressive renal graft failure associated with interferon-alpha treatment in a patient with chronic myelogenous leukemia.
    Bren A; Kandus A; Ferluga D
    Clin Nephrol; 1998 Oct; 50(4):266-7. PubMed ID: 9799075
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.
    Fiorani C; Sacchi S; Bonacorsi G; Cosenza M
    Haematologica; 2000 Sep; 85(9):1006-7. PubMed ID: 10980653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic myeloid leukemia--treatment].
    Stoetzer OJ; Hentrich M; Salat C
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2621-4. PubMed ID: 12469275
    [No Abstract]   [Full Text] [Related]  

  • 17. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
    Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
    Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major depression and psoriasis activation due to interferon-alpha in a patient with chronic myeloid leukemia; "overlooked and/or misdiagnosed adverse reaction in malignant disease".
    Besisik SK; Kocabey G; Caliskan Y
    Am J Hematol; 2003 Nov; 74(3):224. PubMed ID: 14587060
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of interferon-alpha on the prognosis of bone marrow transplantation in chronic myeloid leukemia].
    Xu L; Guo N; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):589-91. PubMed ID: 11855148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia.
    Ladoyanni E; Nambi R
    J Drugs Dermatol; 2005; 4(2):221-2. PubMed ID: 15776781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.